REGN-9930

N/A

Report date: 2026/03/19 16:57:26

Base Information

Drug NameREGN-9930

Drug Alias Nameanti-CD3/anti-MAGE-A4 dual-targeting 2+2 bispecific antibody (Regeneron Pharmaceuticals)Anti-CD3/Anti-MAGE-A4(230-239)/Anti-MAGE-A4(286-294)/HLA-A*0201 T-cell Engager (Regeneron Pharmaceuticals)REGN-9930

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsMelanoma-associated antigen 4 modulatorsHLA Class I Histocompatibility Antigen, A-2 alpha Chain modulators

TargetsT cell surface glycoprotein CD3Melanoma-associated antigen 4HLA Class I Histocompatibility Antigen, A-2 alpha Chain

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRegeneron Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesRegeneron Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A